PAD - Prescribing Advisory Database
PLEASE NOTE : This is a development system.

For Surrey PAD, please go to https://surreyccg.res-systems.net/PAD.

You are here : Home > PAD Profile : Ferric maltol - Iron-deficiency anaemia

PAD Profile : Ferric maltol - Iron-deficiency anaemia

Keywords :
Iron deficiency anaemia, IDA, iron supplements, iron supplementation, iron replacement therapy
Brand Names Include :
Feraccru

Traffic Light Status

Status 1 of 2.

Status :
See Below
Formulations :
  • Not Specified
Trust Alignment :
Primary Care
ASPH
RSFT
SASH
SABP
Links :
Comments :
No comments returned.
Documents :

Status 2 of 2.

Status :
Green (see narrative)
Formulations :
  • Capsules
Trust Alignment :
Primary Care
ASPH
RSFT
SASH
SABP
Links :
Comments :
No comments returned.
Documents :

Guidelines

No guidelines returned.

Other Drugs

No drugs returned.

Other Indications

No indications returned.

Additional Documents

Committee Recommendations

Date
Committee Name
Narrative
07 December 2022
Surrey Heartlands Integrated Care System Area Prescribing Committee (APC)

The Surrey Heartlands integrated care system Area Prescribing Committee (APC) agreed the following traffic lights status for iron preparations for iron deficiency anaemia as follows:

GREEN traffic light status - preferred
•    Ferrous Sulfate 200mg tablets
•    Ferrous Fumerate 210mg tablets
•    Ferrous Gluconate 300mg tablets

GREEN
•    Sodium Feredetate liquid – where a liquid is needed

GREEN
•    Ferric Maltol 30mg capsules – reserved as a last option before referral and if parenteral iron is being considered

11 October 2017
Epsom St Helier NDAIG
SDCCG and EPSOM ST HELIER - RED STATUS The New Drugs & Interface Committee agreed that Ferracru (Ferric maltol) is available to be prescribed in the Trust by consultant gastroenterologists (or gastroenterology Specialist registrars under the guidance of gastro consultants) in IBD patients only. It has a place as an oral iron therapy in patients intolerant to at least one oral ferrous iron salt as an alternative to iv iron therapy. It is usually prescribed for 2-3 months from secondary care

Associated BNF Codes

09. Nutrition and Blood
09.01.01. Iron-deficiency anaemias
This site uses its own and third party cookies to function properly and to improve performance, to maintain the session and to personalise user experience, as well as to obtain anonymous statistics about the use of the website. Visit our Privacy and Cookie Policy for more information on our data collection practices. By clicking 'Accept' you agree to our use of cookies for the purposes listed.
Learn More